30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Candel Therapeutics Inc (CADL)

Track

The most recent insider trading activity occurred on February 23, 2026, with a significant buy transaction by Paul B. Manning. Prior to this, a series of planned and proposed sales by various executives took place in March 2025. The last earnings report was on May 7, 2026.
Stock chart
Ticker: CADL Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Manning Paul B
1 purchase — total 2,999,996 USD
Buy 23 Feb 2026
Value US$3,367,613.79 | Price 435.74 | Shares 49,232
Planned sale 28 Jul 2025
Value US$4,280,267.60 | Price 391.45 | Shares 28,652
Planned sale 30 Jun 2025
Value US$3,936.24 | Price 5.04 | Shares 781
Planned sale 19 Mar 2025
Value US$3,601.00 | Price 9.00 | Shares 400
Planned sale 18 Mar 2025
Value US$396,995.35 | Price 8.76 | Shares 45,316
Planned sale 18 Mar 2025
Value US$281,672.90 | Price 8.76 | Shares 32,146
Planned sale 18 Mar 2025
Value US$226,023.02 | Price 8.77 | Shares 25,772
Proposed sale 18 Mar 2025
Value US$283,849.18 | Price 8.83 | Shares 32,146
Proposed sale 18 Mar 2025
Value US$654,355.98 | Price 8.83 | Shares 74,106
Proposed sale 18 Mar 2025
Value US$400,140.28 | Price 8.83 | Shares 45,316
Planned sale 17 Mar 2025
Value US$275,947.03 | Price 8.82 | Shares 31,278
Planned sale 17 Mar 2025
Value US$44,169.00 | Price 8.83 | Shares 5,000
Proposed sale 17 Mar 2025
Value US$273,682.50 | Price 8.75 | Shares 31,278
Proposed sale 17 Mar 2025
Value US$43,750.00 | Price 8.75 | Shares 5,000
Sale 15 Jan 2025
Value US$103,476.45 | Price 7.23 | Shares 14,322
Proposed sale 15 Jan 2025
Value US$103,307.68 | Price 7.84 | Shares 13,177
Sale 15 Jan 2025
Value US$68,716.98 | Price 7.23 | Shares 9,511
Proposed sale 15 Jan 2025
Value US$68,607.84 | Price 7.84 | Shares 8,751
Sale 15 Jan 2025
Value US$156,811.40 | Price 7.23 | Shares 21,704
Proposed sale 15 Jan 2025
Value US$156,564.80 | Price 7.84 | Shares 19,970
Sale 15 Jan 2025
Value US$97,783.15 | Price 7.23 | Shares 13,534
Proposed sale 15 Jan 2025
Value US$97,623.68 | Price 7.84 | Shares 12,452
Sale 15 Jan 2025
Value US$75,342.30 | Price 7.23 | Shares 10,428
Proposed sale 15 Jan 2025
Value US$75,216.96 | Price 7.86 | Shares 9,564
Sale 8 Jan 2025
Value US$173,995.73 | Price 8.22 | Shares 21,172
Proposed sale 8 Jan 2025
Value US$173,771.85 | Price 8.35 | Shares 20,811
Sale 8 Jan 2025
Value US$81,943.67 | Price 8.22 | Shares 9,971
Proposed sale 8 Jan 2025
Value US$81,838.35 | Price 8.35 | Shares 9,801
Sale 8 Jan 2025
Value US$112,367.45 | Price 8.22 | Shares 13,673
Proposed sale 8 Jan 2025
Value US$112,224.00 | Price 8.35 | Shares 13,440
Sale 8 Jan 2025
Value US$119,533.72 | Price 8.22 | Shares 14,545
Proposed sale 8 Jan 2025
Value US$119,379.95 | Price 8.35 | Shares 14,297
Sale 8 Jan 2025
Value US$88,749.42 | Price 8.22 | Shares 10,799
Proposed sale 8 Jan 2025
Value US$88,626.90 | Price 8.35 | Shares 10,614
Buy 16 Dec 2024
Value US$4,500,000.00 | Price 6.00 | Shares 750,000
Buy 16 Dec 2024
Value US$3,000,000.00 | Price 6.00 | Shares 500,000
Sale 29 Nov 2024
Value US$100,592.20 | Price 4.56 | Shares 22,081
Proposed sale 29 Nov 2024
Value US$99,420.75 | Price 4.95 | Shares 20,085
Sale 29 Nov 2024
Value US$63,482.29 | Price 4.56 | Shares 13,935
Proposed sale 29 Nov 2024
Value US$62,741.25 | Price 4.95 | Shares 12,675
Sale 29 Nov 2024
Value US$222,527.39 | Price 4.56 | Shares 48,847
Proposed sale 29 Nov 2024
Value US$219,943.35 | Price 4.95 | Shares 44,433
Sale 29 Nov 2024
Value US$92,897.80 | Price 4.56 | Shares 20,392
Proposed sale 29 Nov 2024
Value US$91,812.60 | Price 4.95 | Shares 18,548
Sale 15 Oct 2024
Value US$62,784.36 | Price 6.03 | Shares 10,412
Sale 14 Oct 2024
Value US$90,300.00 | Price 6.02 | Shares 15,000
Sale 11 Oct 2024
Value US$90,750.00 | Price 6.05 | Shares 15,000
Sale 3 Oct 2024
Value US$12,330.00 | Price 6.85 | Shares 1,800
Sale 2 Oct 2024
Value US$186,756.96 | Price 6.92 | Shares 26,988
Proposed sale 23 Sep 2024
Value US$199,360.00 | Price 7.00 | Shares 28,480
Proposed sale 13 Sep 2024
Value US$187,460.00 | Price 6.50 | Shares 28,840
Sale 17 Jul 2024
Value US$90,946.50 | Price 6.47 | Shares 14,051
Proposed sale 17 Jul 2024
Value US$90,796.95 | Price 7.29 | Shares 12,455
Sale 17 Jul 2024
Value US$63,975.18 | Price 6.47 | Shares 9,884
Proposed sale 17 Jul 2024
Value US$63,867.69 | Price 7.29 | Shares 8,761
Sale 17 Jul 2024
Value US$145,814.73 | Price 6.47 | Shares 22,528
Proposed sale 17 Jul 2024
Value US$145,581.30 | Price 7.29 | Shares 19,970
Sale 17 Jul 2024
Value US$96,124.58 | Price 6.47 | Shares 14,851
Proposed sale 17 Jul 2024
Value US$95,965.56 | Price 7.29 | Shares 13,164
Sale 17 Jul 2024
Value US$70,389.52 | Price 6.47 | Shares 10,875
Proposed sale 17 Jul 2024
Value US$70,275.60 | Price 7.29 | Shares 9,640
Sale 11 Jul 2024
Value US$79,625.42 | Price 5.97 | Shares 13,330
Proposed sale 11 Jul 2024
Value US$77,652.64 | Price 5.92 | Shares 13,117
Sale 11 Jul 2024
Value US$121,218.21 | Price 5.97 | Shares 20,293
Proposed sale 11 Jul 2024
Value US$118,222.40 | Price 5.92 | Shares 19,970
Sale 11 Jul 2024
Value US$58,354.14 | Price 5.97 | Shares 9,769
Proposed sale 11 Jul 2024
Value US$56,908.96 | Price 5.92 | Shares 9,613
Sale 11 Jul 2024
Value US$53,145.34 | Price 5.97 | Shares 8,897
Proposed sale 11 Jul 2024
Value US$51,823.68 | Price 5.92 | Shares 8,754
Sale 11 Jul 2024
Value US$75,533.64 | Price 5.97 | Shares 12,645
Proposed sale 11 Jul 2024
Value US$73,662.56 | Price 5.92 | Shares 12,443
Buy 9 Dec 2022
Value US$24,835.20 | Price 1.92 | Shares 12,935
Buy 9 Dec 2022
Value US$4,763.24 | Price 1.93 | Shares 2,468
Buy 9 Dec 2022
Value US$19,990.94 | Price 1.93 | Shares 10,358
Buy 9 Dec 2022
Value US$45,984.00 | Price 1.92 | Shares 23,950
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-26 2026-02-23 B Purchase
4.0
Manning Paul B
Non-Executive Director
49,232 +22.5%
435.74
US$3,367,614 		49,232 +22.5% 435.74 US$3,367,614
2025-07-30 2025-07-28 PlS Planned sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
28,652 +25.9%
391.45
US$4,280,268 		28,652 +25.9% 391.45 US$4,280,268
2025-07-02 2025-06-30 PlS Planned sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
60,385 -42.6%
256.11
US$3,867,448 		60,385 -42.6% 256.11 US$3,867,448
2025-03-20 2025-03-19 PlS Planned sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
400 -0.2%
9.00
US$3,601 		400 -0.2% 9.00 US$3,601
2025-03-20 2025-03-18 PlS Planned sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
45,316 -46.3%
8.76
US$396,995 		45,316 -46.3% 8.76 US$396,995
2025-03-20 2025-03-18 PlS Planned sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
32,146 -25.0%
8.76
US$281,673 		32,146 -25.0% 8.76 US$281,673
2025-03-20 2025-03-18 PlS Planned sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
25,772 -10.2%
8.77
US$226,023 		25,772 -10.2% 8.77 US$226,023
2025-03-18 2025-03-18 PrS Proposed sale
3.0
FRANCESCA BARONE

Officer

Officer
32,146
8.83
US$283,849 		32,146 8.83 US$283,849
2025-03-18 2025-03-18 PrS Proposed sale
2.9
PAUL PETER TAK

Director; Officer

Executive Director
74,106
8.83
US$654,356 		74,106 8.83 US$654,356
2025-03-18 2025-03-18 PrS Proposed sale
3.0
WILLIAM GARRETT NICHOLS

Officer

Officer
45,316
8.83
US$400,140 		45,316 8.83 US$400,140
2025-03-19 2025-03-17 PlS Planned sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
31,278 -26.8%
8.82
US$275,947 		31,278 -26.8% 8.82 US$275,947
2025-03-19 2025-03-17 PlS Planned sale
3.2
Schoch Charles

See Remarks

Officer
5,000 -11.6%
8.83
US$44,169 		5,000 -11.6% 8.83 US$44,169
2025-03-17 2025-03-17 PrS Proposed sale
3.3
SESHU TYAGARAJAN

Officer

Officer
31,278
8.75
US$273,682 		31,278 8.75 US$273,682
2025-03-17 2025-03-17 PrS Proposed sale
3.2
CHARLES SCHOCH

Officer

Officer
5,000
8.75
US$43,750 		5,000 8.75 US$43,750
2025-01-17 2025-01-15 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
14,322 -12.9%
7.23
US$103,476 		14,322 -12.9% 7.23 US$103,476
2025-01-17 2025-01-15 S Sale
3.2
Schoch Charles

See Remarks

Officer
9,511 -18.1%
7.23
US$68,717 		9,511 -18.1% 7.23 US$68,717
2025-01-17 2025-01-15 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
21,704 -7.9%
7.23
US$156,811 		21,704 -7.9% 7.23 US$156,811
2025-01-17 2025-01-15 S Sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
13,534 -10.9%
7.23
US$97,783 		13,534 -10.9% 7.23 US$97,783
2025-01-17 2025-01-15 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
10,428 -11.6%
7.23
US$75,342 		10,428 -11.6% 7.23 US$75,342
2025-01-15 2025-01-15 PrS Proposed sale
3.3
Tyagarajan Seshu

Officer

Officer
13,177
7.84
US$103,308 		13,177 7.84 US$103,308
2025-01-15 2025-01-15 PrS Proposed sale
3.0
Nichols William Garrett

Officer

Officer
9,564
7.86
US$75,217 		9,564 7.86 US$75,217
2025-01-15 2025-01-15 PrS Proposed sale
3.0
Barone Francesca

Officer

Officer
12,452
7.84
US$97,624 		12,452 7.84 US$97,624
2025-01-15 2025-01-15 PrS Proposed sale
3.2
Schoch Charles

Officer

Officer
8,751
7.84
US$68,608 		8,751 7.84 US$68,608
2025-01-15 2025-01-15 PrS Proposed sale
2.9
Tak Paul Peter

Officer; Director

Executive Director
19,970
7.84
US$156,565 		19,970 7.84 US$156,565
2025-01-10 2025-01-08 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
21,172 -7.2%
8.22
US$173,996 		21,172 -7.2% 8.22 US$173,996
2025-01-10 2025-01-08 S Sale
3.2
Schoch Charles

See Remarks

Officer
9,971 -15.9%
8.22
US$81,944 		9,971 -15.9% 8.22 US$81,944
2025-01-10 2025-01-08 S Sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
13,673 -9.9%
8.22
US$112,367 		13,673 -9.9% 8.22 US$112,367
2025-01-10 2025-01-08 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
14,545 -11.6%
8.22
US$119,534 		14,545 -11.6% 8.22 US$119,534
2025-01-10 2025-01-08 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
10,799 -10.7%
8.22
US$88,749 		10,799 -10.7% 8.22 US$88,749
2025-01-08 2025-01-08 PrS Proposed sale
3.3
Tyagarajan Seshu

Officer

Officer
14,297
8.35
US$119,380 		14,297 8.35 US$119,380
2025-01-08 2025-01-08 PrS Proposed sale
2.9
Tak Paul Peter

Officer; Director

Executive Director
20,811
8.35
US$173,772 		20,811 8.35 US$173,772
2025-01-08 2025-01-08 PrS Proposed sale
3.0
Nichols William Garrett

Officer

Officer
10,614
8.35
US$88,627 		10,614 8.35 US$88,627
2025-01-08 2025-01-08 PrS Proposed sale
3.0
Barone Francesca

Officer

Officer
13,440
8.35
US$112,224 		13,440 8.35 US$112,224
2025-01-08 2025-01-08 PrS Proposed sale
3.2
Schoch Charles

Officer

Officer
9,801
8.35
US$81,838 		9,801 8.35 US$81,838
2024-12-18 2024-12-16 B Purchase
4.0
Manning Paul B
Non-Executive Director
750,000 +135.4%
6.00
US$4,500,000 		750,000 +135.4% 6.00 US$4,500,000
2024-12-18 2024-12-16 B Purchase
4.0
Manning Paul B
Non-Executive Director
500,000 +77.8%
6.00
US$3,000,000 		500,000 +77.8% 6.00 US$3,000,000
2024-12-03 2024-11-29 S Sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
22,081 -13.8%
4.56
US$100,592 		22,081 -13.8% 4.56 US$100,592
2024-12-03 2024-11-29 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
13,935 -12.2%
4.56
US$63,482 		13,935 -12.2% 4.56 US$63,482
2024-12-03 2024-11-29 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
48,847 -14.2%
4.56
US$222,527 		48,847 -14.2% 4.56 US$222,527
2024-12-03 2024-11-29 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
20,392 -14.0%
4.56
US$92,898 		20,392 -14.0% 4.56 US$92,898
2024-11-29 2024-11-29 PrS Proposed sale
3.3
Tyagarajan Seshu

Officer

Officer
18,548
4.95
US$91,813 		18,548 4.95 US$91,813
2024-11-29 2024-11-29 PrS Proposed sale
2.9
Tak Paul Peter

Officer; Director

Executive Director
44,433
4.95
US$219,943 		44,433 4.95 US$219,943
2024-11-29 2024-11-29 PrS Proposed sale
3.0
Nichols William Garrett

Officer

Officer
12,675
4.95
US$62,741 		12,675 4.95 US$62,741
2024-11-29 2024-11-29 PrS Proposed sale
3.0
Barone Francesca

Officer

Officer
20,085
4.95
US$99,421 		20,085 4.95 US$99,421
2024-10-15 2024-10-15 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
10,412 -1.1%
6.03
US$62,784 		10,412 -1.1% 6.03 US$62,784
2024-10-15 2024-10-14 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
15,000 -1.6%
6.02
US$90,300 		15,000 -1.6% 6.02 US$90,300
2024-10-15 2024-10-11 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
15,000 -1.6%
6.05
US$90,750 		15,000 -1.6% 6.05 US$90,750
2024-10-03 2024-10-03 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
1,800 -0.2%
6.85
US$12,330 		1,800 -0.2% 6.85 US$12,330
2024-10-03 2024-10-02 S Sale
1.9
Aguilar-Cordova Estuardo
Large shareholder
26,988 -2.7%
6.92
US$186,757 		26,988 -2.7% 6.92 US$186,757
2024-09-23 2024-09-23 PrS Proposed sale
1.9
Aguilar-Cordova Estuardo

Director

Non-Executive Director
28,480
7.00
US$199,360 		28,480 7.00 US$199,360
2024-09-13 2024-09-13 PrS Proposed sale
1.9
Aguilar-Cordova Estuardo

Director

Non-Executive Director
28,840
6.50
US$187,460 		28,840 6.50 US$187,460
2024-07-19 2024-07-17 S Sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
14,051 -8.1%
6.47
US$90,947 		14,051 -8.1% 6.47 US$90,947
2024-07-19 2024-07-17 S Sale
3.2
Schoch Charles

See Remarks

Officer
9,884 -13.7%
6.47
US$63,975 		9,884 -13.7% 6.47 US$63,975
2024-07-19 2024-07-17 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
22,528 -6.4%
6.47
US$145,815 		22,528 -6.4% 6.47 US$145,815
2024-07-19 2024-07-17 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
14,851 -9.2%
6.47
US$96,125 		14,851 -9.2% 6.47 US$96,125
2024-07-19 2024-07-17 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
10,875 -8.7%
6.47
US$70,390 		10,875 -8.7% 6.47 US$70,390
2024-07-17 2024-07-17 PrS Proposed sale
3.3
Tyagarajan Seshu

Officer

Officer
13,164
7.29
US$95,966 		13,164 7.29 US$95,966
2024-07-17 2024-07-17 PrS Proposed sale
2.9
Tak Paul Peter

Officer; Director

Executive Director
19,970
7.29
US$145,581 		19,970 7.29 US$145,581
2024-07-17 2024-07-17 PrS Proposed sale
3.2
Schoch Charles

Officer

Officer
8,761
7.29
US$63,868 		8,761 7.29 US$63,868
2024-07-17 2024-07-17 PrS Proposed sale
3.0
Nichols William Garrett

Officer

Officer
9,640
7.29
US$70,276 		9,640 7.29 US$70,276
2024-07-17 2024-07-17 PrS Proposed sale
3.0
Barone Francesca

Officer

Officer
12,455
7.29
US$90,797 		12,455 7.29 US$90,797
2024-07-15 2024-07-11 S Sale
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
13,330 -7.7%
5.97
US$79,625 		13,330 -7.7% 5.97 US$79,625
2024-07-15 2024-07-11 S Sale
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
20,293 -5.4%
5.97
US$121,218 		20,293 -5.4% 5.97 US$121,218
2024-07-15 2024-07-11 S Sale
3.0
Nichols William Garrett

Chief Medical Officer

Officer
9,769 -7.2%
5.97
US$58,354 		9,769 -7.2% 5.97 US$58,354
2024-07-15 2024-07-11 S Sale
3.2
Schoch Charles

See Remarks

Officer
8,897 -10.9%
5.97
US$53,145 		8,897 -10.9% 5.97 US$53,145
2024-07-15 2024-07-11 S Sale
3.0
Barone Francesca

Chief Scientific Officer

Officer
12,645 -6.8%
5.97
US$75,534 		12,645 -6.8% 5.97 US$75,534
2024-07-11 2024-07-11 PrS Proposed sale
3.3
Tyagarajan Seshu

Officer

Officer
13,117
5.92
US$77,653 		13,117 5.92 US$77,653
2024-07-11 2024-07-11 PrS Proposed sale
2.9
Tak Paul Peter

Officer; Director

Executive Director
19,970
5.92
US$118,222 		19,970 5.92 US$118,222
2024-07-11 2024-07-11 PrS Proposed sale
3.2
Schoch Charles

Officer

Officer
8,754
5.92
US$51,824 		8,754 5.92 US$51,824
2024-07-11 2024-07-11 PrS Proposed sale
3.0
Nichols William Garrett

Officer

Officer
9,613
5.92
US$56,909 		9,613 5.92 US$56,909
2024-07-11 2024-07-11 PrS Proposed sale
3.0
Barone Francesca

Officer

Officer
12,443
5.92
US$73,663 		12,443 5.92 US$73,663
2022-12-12 2022-12-09 B Purchase
2.9
Tak Paul Peter

Chief Executive Officer

Executive Director
12,935 +46.1%
1.92
US$24,835 		12,935 +46.1% 1.92 US$24,835
2022-12-12 2022-12-09 B Purchase
2.1
Amello Jason

Chief Financial Officer

Officer
2,468 +79.6%
1.93
US$4,763 		2,468 +79.6% 1.93 US$4,763
2022-12-12 2022-12-09 B Purchase
3.3
Tyagarajan Seshu

Chief Technology Officer

Officer
10,358 +345.3%
1.93
US$19,991 		10,358 +345.3% 1.93 US$19,991
2022-12-12 2022-12-09 B Purchase
3.1
Martell Christopher
Non-Executive Director
23,950 +18.7%
1.92
US$45,984 		23,950 +18.7% 1.92 US$45,984
Explore more

More insider trading research around Candel Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America